SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Democratic gains in the midterms have fueled concern that tighter AI rules and data-center permitting delays could slow the buildout supporting Nvidias sales, weighing on the stock alongside broader semiconductor weakness. Traders disagree on whether the policy fears and doubts about AI spending are real threats or overblown, with some buying the dip on expectations that demand will persist.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a semiconductor selloff as traders worry Democratic election gains could bring tighter oversight or slower permitting for AI data centers, threatening the buildout that supports memory demand. The community is split between those who see the AI trade and memory pricing outlook weakening and bulls who view the decline as an overreaction, arguing that AI demand and data-center construction will persist.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms quarterly results sparked debate: a modest earnings beat and stronger revenue outlook were offset by a softer EPS outlook, sharply weaker handset sales, and rising component costs. Traders are weighing whether growth in automotive, data center and other non-handset businesses can offset pressure on the phone-chip business.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arms quarterly results beat expectations, but shares sold off as traders focused on modest forward guidance and slower royalty growth despite strong licensing and data-center demand. The reaction reflects concern that strong results may not justify the stocks valuation amid weakness across AI and semiconductor shares, while some traders view the pullback as a buying opportunity.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastlys quarterly results beat estimates and management raised its full-year outlook, but shares sold off sharply after the report. Traders are debating whether the decline reflects expectations that were even higher, with bullish posters pointing to improving margins and cash flow while others focus on the weak price reaction and volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisks selloff is drawing attention amid concerns that Democratic gains in Congress could bring tighter AI and data-center rules, slowing infrastructure buildouts and demand for memory chips. Traders are split between seeing the policy fears and broader chip-sector weakness as an overreaction, with memory demand intact, and fearing a longer AI-investment or memory-cycle downturn.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXLs steep decline is being tied to broad semiconductor selling and trader concerns that the Democratic midterm sweep could bring tighter scrutiny or delays for AI data centers, weighing on chip demand. The community is split between bearish claims that the AI trade is ending and dip buyers who view the selloff as an overreaction; SOXLs 3x leverage magnifies the swings.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is drawing attention after traders highlighted a reported quarterly beat and raised revenue guidance, alongside progress in its oncology pipeline. Reactions remain mixed: some see the update as evidence of improving momentum, while others remain cautious about clinical setbacks and leadership changes.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers quarterly report drew attention after adjusted earnings and revenue topped expectations and gross bookings grew strongly, while investors debated whether the softer-than-expected outlook and weakness in Mobility offset solid cash generation and growth in Delivery. Traders also focused on the planned expansion of driverless vehicles, but reactions to the report were mixed, with some welcoming the underlying results and others citing guidance and competitive risks.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA filing for sonelokimab in hidradenitis suppurativa has put the FDAs review-acceptance and review-timeline decisions in focus. Traders are divided: bulls see the filing and clinical data as important progress, while bears worry about regulatory risk, a go-it-alone commercial strategy, and potential future dilution amid the share-price decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insulet CEO Sees Slower Growth in 2027, Expects Rivals to Chip Away at Omnipod's Market Share

Insulet stock jumps on strong Q3 results, beating estimates with $842M in revenue, raising its 2026 outlook, and launching a $1B buyback.read more...

Insulet Q3 2026 Earnings Call Transcript

Insulet (NASDAQ:PODD) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Insulet (PODD) Q3 Earnings and Revenues Surpass Estimates

Insulet (PODD) delivered earnings and revenue surprises of +25.16% and +1.04%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Insulet Reports Third Quarter 2026 Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced its financial results for the three months ended September 30, 2026. Third Quarter Financial Highlights: Revenue of $842.0 million...

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that management will present at the 2026 Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 10:30 a.m. (GMT). The live...

Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study

DXCM's G7 delivers strong results in the CONNECT study, improving A1C levels and glucose control in non-insulin users with Type 2 diabetes, supporting CGM adoption.

Here's Why Insulet (PODD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Insulet Announces Omnipod Discover Now Available in U.S.

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the U.S. full market release of Omnipod Discover, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs...

$PODD Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.99 up 60.48% YoY
• Reported revenue of $842M up 19.21% YoY
• Insulets FY 2026 total revenue growth guidance is 21% - 22% in constant currency; adjusted operating margin guidance is ~150 bps YoY expansion, from ~100 bps, and adjusted EPS growth is &gt;30%.

Stocktwits

Insulet Corporation

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.99 up 60.48% YoY
• Reported revenue of $842M up 19.21% YoY
• Insulets FY 2026 total revenue growth guidance is 21% - 22% in constant currency; adjusted operating margin guidance is ~150 bps YoY expansion, from ~100 bps, and adjusted EPS growth is >30%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $1.99 up 60.48% YoY
• Reported revenue of $842M up 19.21% YoY
• Insulets FY 2026 total revenue growth guidance is 21% - 22% in constant currency; adjusted operating margin guidance is ~150 bps YoY expansion, from ~100 bps, and adjusted EPS growth is >30%.

Insulet reported lower nine-month free cash flow and Drug Delivery revenue versus prior-year periods, and identifies dependence on a principal product platform and manufacturing concentration as risks.

Insulet reported Omnipod revenue growth, completed Omnipod Discovers U.S. release with adoption by more than 35,000 users, extended Libre 3 Plus integration internationally, and completed enrollment in two clinical trials.

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PODD News